Temozolomide

Last Updated: 09/19/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12797 publications

Tropolone Derivative JO-122(2) Enhances Temozolomide Efficacy and p53-Mediated Apoptosis in Glioblastoma Xenografts.

Tropolone Derivative JO-122(2) Enhances Temozolomide Efficacy and p53-Mediated Apoptosis in Glioblastoma Xenografts.

Journal: Iranian biomedical journal
Published: September 04, 2026

Multifaceted Temozolomide Toxicity in Glioma: Detection & Care.

Multifaceted Temozolomide Toxicity in Glioma: Detection & Care.

Journal: La Clinica terapeutica
Published: August 28, 2026

Secondary Renal Cell Carcinoma Bearing the Genomic Signature of Prior Temozolomide Therapy.

Secondary Renal Cell Carcinoma Bearing the Genomic Signature of Prior Temozolomide Therapy.

Journal: JCO precision oncology
Published: August 26, 2026

Drug Therapy for Glioblastoma:Standard and Novel Treatments

Drug Therapy for Glioblastoma:Standard and Novel Treatments

Journal: No shinkei geka. Neurological surgery
Published: August 16, 2026

Treatment of Lower-Grade Glioma:Emergence of IDH Inhibitors and Changes in Therapeutic Decision-Making

Treatment of Lower-Grade Glioma:Emergence of IDH Inhibitors and Changes in Therapeutic Decision-Making

Journal: No shinkei geka. Neurological surgery
Published: August 16, 2026

Circulating miRNAs for glioblastoma monitoring: from biofluid to clinical decision.

Circulating miRNAs for glioblastoma monitoring: from biofluid to clinical decision.

Journal: Molecular therapy. Oncology
Published: August 16, 2026

Depatuxizumab mafodotin in glioblastoma: A systematic review of efficacy, safety, pharmacokinetics and biomarker stratification.

Depatuxizumab mafodotin in glioblastoma: A systematic review of efficacy, safety, pharmacokinetics and biomarker stratification.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: August 05, 2026

USP33-mediated deubiquitination stabilizes YTHDF2 and promotes glioblastoma malignancy and temozolomide resistance.

USP33-mediated deubiquitination stabilizes YTHDF2 and promotes glioblastoma malignancy and temozolomide resistance.

Journal: Biochemical and biophysical research communications
Published: July 27, 2026

Pregnancy and neonatal outcomes in patients treated for glioma before or during pregnancy: a single-institution retrospective series.

Pregnancy and neonatal outcomes in patients treated for glioma before or during pregnancy: a single-institution retrospective series.

Journal: Journal of neuro-oncology
Published: July 26, 2026

Rewiring mitotic checkpoint control via Mps1 inhibition overcomes DNA repair-mediated resistance in glioblastoma.

Rewiring mitotic checkpoint control via Mps1 inhibition overcomes DNA repair-mediated resistance in glioblastoma.

Journal: The Journal of biological chemistry
Published: July 24, 2026

Cytostatic autophagy: an underappreciated form of autophagy and its ramifications in cancer.

Cytostatic autophagy: an underappreciated form of autophagy and its ramifications in cancer.

Journal: Autophagy
Published: July 24, 2026

Real-World Survival Outcomes of Glioblastoma Patients Under Universal Temozolomide Access in Uruguay: A Retrospective Cohort Study (2009-2018) and Implications for Health Policy.

Real-World Survival Outcomes of Glioblastoma Patients Under Universal Temozolomide Access in Uruguay: A Retrospective Cohort Study (2009-2018) and Implications for Health Policy.

Journal: Cureus
Published: July 24, 2026
Showing 1-12 of 12,797

Last Updated: 09/19/2026